These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 182629)
1. Interactions of glucagon and related peptides with chicken adipose tissue. Kitabgi P; Rosselin G; Bataille D Horm Metab Res; 1976 Jul; 8(4):266-70. PubMed ID: 182629 [TBL] [Abstract][Full Text] [Related]
2. The action of gut glucagon-like immunoreactivity and other intestinal hormones on lipolysis in chicken adipocytes. Langslow DR Horm Metab Res; 1973 Nov; 5(6):428-32. PubMed ID: 4766997 [No Abstract] [Full Text] [Related]
3. In vitro interactions of gastrointestinal hormones on cyclic adenosine 3':5'-monophosphate levels and amylase output in the rat pancreas. Deschodt-Lanckman M; Robberecht P; De Neef P; Labrie F; Christophe J Gastroenterology; 1975 Feb; 68(2):318-25. PubMed ID: 163779 [TBL] [Abstract][Full Text] [Related]
5. Effects of gastrointestinal hormones and carbamylcholine on cAMP accumulation in isolated pancreatic duct fragments from the rat. Fölsch UR; Fischer H; Söling HD; Creutzfeldt W Digestion; 1980; 20(4):277-92. PubMed ID: 6248407 [TBL] [Abstract][Full Text] [Related]
6. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB; Niewiadomski P; Nowak JZ Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptide. Dupre J; Greenidge N; McDonald TJ; Ross SA; Rubinstein D Metabolism; 1976 Nov; 25(11):1197-9. PubMed ID: 185484 [TBL] [Abstract][Full Text] [Related]
8. [Glucagon receptor binding and its effect on the cAMP level in isolated rat and chicken hepatocytes]. Leĭbush BN; Ukhanova MV Fiziol Zh SSSR Im I M Sechenova; 1990 Sep; 76(9):1153-8. PubMed ID: 1963855 [TBL] [Abstract][Full Text] [Related]
9. Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with their membrane receptors. Bataille D; Rosselin G; Freychet P Isr J Med Sci; 1975 Jul; 11(7):687-92. PubMed ID: 169214 [No Abstract] [Full Text] [Related]
10. Lack of feedback regulation of cyclic 3':5'-AMP accumulation by free fatty acids in chicken fat cells. Malgieri JA; Shepherd RE; Fain JN J Biol Chem; 1975 Aug; 250(16):6593-8. PubMed ID: 169253 [TBL] [Abstract][Full Text] [Related]
11. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes. Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623 [TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor. Birnbaum RS; Alfonzo M; Kowal J Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149 [TBL] [Abstract][Full Text] [Related]
13. Ontogeny of glucagon and isoproterenol induced cyclic 3'-5' adenosine monophosphate production in adipocytes isolated from the inguinal adipose tissue of developing rats. Gaben AM; Jahchan T; Swierczewski W; Rosselin G J Dev Physiol; 1982 Feb; 4(1):75-83. PubMed ID: 6179979 [TBL] [Abstract][Full Text] [Related]
14. Quantitative studies of vasoactive intestinal peptide (VIP) binding sites and VIP-induced adenosine 3':5'-monophosphate production in epithelial cells from duodenum, jejunum, ileum, cecum, colon and rectum in the rat. Prieto JC; Laburthe M; Hoa DH; Rosselin G Acta Endocrinol (Copenh); 1981 Jan; 96(1):100-6. PubMed ID: 6257013 [TBL] [Abstract][Full Text] [Related]
15. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach. Chiba T; Taminato T; Kadowaki S; Abe H; Chihara K; Seino Y; Matsukura S; Fujita T Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859 [TBL] [Abstract][Full Text] [Related]
16. Antilipolytic nature of gut GLI, and mode of action of two highly potent intestinal lipolytic species in birds. Krug E Horm Metab Res; 1978 Nov; 10(6):505-9. PubMed ID: 217810 [TBL] [Abstract][Full Text] [Related]
17. [Studies on adipocyte glucagon receptor assay--with special reference to the effect of cold acclimation on glucagon receptors of white adipocytes]. Uehara A Hokkaido Igaku Zasshi; 1985 May; 60(3):375-90. PubMed ID: 2991098 [TBL] [Abstract][Full Text] [Related]
18. Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase. Bataille D; Freychet P; Rosselin G Endocrinology; 1974 Sep; 95(3):713-21. PubMed ID: 4368831 [No Abstract] [Full Text] [Related]
19. Effect of secretin and VIP on isolated pancreatic duct fragments in vitro. Creutzfeldt W; Foelsch UR Endocrinol Jpn; 1980 Dec; 27 Suppl 1():59-63. PubMed ID: 6262064 [TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Laburthe M; Rousset M; Boissard C; Chevalier G; Zweibaum A; Rosselin G Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2772-5. PubMed ID: 208077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]